Concepedia

Marion Thibaudin

MT

18

Publications

2K

Citations

16

H-Index

2015

Active since

Affiliations

Centre Georges François Leclerc(Current)

Inserm

Centre de recherche Translationnelle en Médecine moléculaire

Genomic and Immunotherapy Medical Institute

Université de Bourgogne

Marion Thibaudin is an author at Centre Georges François Leclerc specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

2015–2023

18

Publications

18

Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance

Alexia K. Cotte, Virginie Aires, Maxime Fredon et al. · Nature Communications · 2018 · 338 citations · Full text

Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen

Emeric Limagne, Romain Euvrard, Marion Thibaudin et al. · Cancer Research · 2016 · 256 citations

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination

M. Grapin, Corentin Richard, Emeric Limagne et al. · Journal for ImmunoTherapy of Cancer · 2019 · 205 citations · Full text

MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells

Emeric Limagne, Lisa Nuttin, Marion Thibaudin et al. · Cancer Cell · 2022 · 199 citations

, , +11

Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients

Emeric Limagne, Corentin Richard, Marion Thibaudin et al. · OncoImmunology · 2019 · 198 citations · Full text

, , +16

Rows per page

1–5 of 18